Statistics

Total Visits

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)90

Select a period of time:

Number of views in the range

Views
BIM and SHP2 expression levels to predict clinical outcome to EGFR tyrosine kinase inhibitors (TKI) in EGFR-mutant non-small-cell lung cancer (NSCLC) patients (p)18

Views

Views
November 202512
December 20253
January 20261
February 20260
March 20262
April 20260
May 20260
Download CSV file
 untranslated
 untranslated

Top country views

Views
Brazil7
United States4
Argentina2
Ecuador1
Peru1
Sweden1
Uruguay1
Venezuela1
 

Top cities views

Views
Belford Roxo1
Buenos Aires1
Gramado1
Guayaquil1
La Plata1
Lima1
Montevideo1
Pouso Alegre1
Salvador1
San Jose1